Type 2 Diabetes (18F-MC-GPGM)
20191112160131

Efficacy and safety of LY3298176 once weekly versus Insulin Glargine in patients with Type 2 Diabetes and increased cardiovascular risk. Register Today!

Plaque Psoriasis (CAIN2322)
20181016131144

Psoriasis is an autoimmune disease that causes raised, red, scaly patches to appear on the skin. It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. Some people report that psoriasis is itchy, burns and stings. Psoriasis can be associated with rheumatoid arthritis, Crohn’s disease, and osteoporosis….

Pediatric Pneumococcal Vaccine (V114-031)
20181016105734

Pneumonia is inflammation of the lungs caused by bacteria, viruses, any in some cases, chemical irritants. It is a serious infection in which air sacs in the lungs fill with liquid making it difficult to breathe. Many different types of pneumonia exist, however, they are preventable through routine vaccines. This study is designed to evaluate…

Type 2 Diabetes Mellitus in Diabetic Kidney Disease (Bayer 17530)
20180824122540

Type 2 Diabetes is a long-term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Diabetic kidney disease or DKD, is one of the most frequent microvascular complications of diabetes and is the leading cause of end-stage kidney disease worldwide. The purpose of this study is to evaluate…

Endometriosis-Associated Pain (M14-702)
20180824120459

Endometriosis is an often times painful disorder in which tissue that normally lines the inside of your uterus, the endometrium, grows outside your uterus. The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects including the safety and efficacy…

Ulcerative Colitis (M14-533)
20170129135823

M14-533 is an extension study of M14-234. The purpose of this study is to evaluate the long-term safety and efficacy of ABT-494 in subjects with Ulcerative Colitis (UC) who have not responded at the end of the induction period in Study M14-234, who have been inadequate responders during the maintenance period of Study M14-234, or…

Ulcerative Colitis (UCO-3001)
20150813142356

Ulcerative colitis is more localized in nature than Crohn’s disease. Typically, the disease affects the colon (large bowel) including the rectum and anus, and only invades the inner lining of bowel tissue. It almost always starts at the rectum, extending upwards in a continuous manner through the colon. Colitis can be controlled with medication and…